Pax Neuroscience is a patented biomarker-based blood test that aids physicians in their diagnosis and treatment efficacy for each patient who has been diagnosed with and is receiving therapy for depression. A variation of this is being developed for a prospective predictive screen that will use a patient's leukocytes to suggest treatment